Ana Lalanne

4PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial.

|Apr 02, 2024
Divergent local and systemic antitumor response in primary uveal melanomas.

Francesca Lucibello, Ana I Lalanne, Anne-Laure Le Gac

|Feb 03, 2023
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.

Antonela Merlotti, Benjamin Sadacca, Yago A Arribas

|Feb 13, 2018
Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.

Slobodan Culina, Ana Ines Lalanne, Georgia Afonso

Pageof 1

Frequent Collaborators

3 joint publications

Olivier Lantz

2 joint publications

Alexandre Houy

2 joint publications

Marc-Henri Stern

1 joint publications

Francesca Lucibello